Coenzyme A S-(3,7,11,15-tetramethylhexadecanoate)
CAS : 146622-45-9
Ref. 3D-WFA62245
1mg | À demander | |
5mg | À demander | |
10mg | À demander | |
25mg | À demander | |
50mg | À demander |
Informations sur le produit
- Coenzyme A, S-(3,7,11,15-tetramethylhexadecanoate)
- Phytanic acid coenzyme A ester
- Phytanoyl-CoA
- S-{1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (3S,7R,11R)-3,7,11,15-tetramethylhexadecanethioate (non-preferred name)
- [(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-2,2-dimethyl-3-[2-[2-[(3S,7S,11R)-3,7,11,15-tetramethylhexadecanoyl]sulfanylethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
Coenzyme A S-(3,7,11,15-tetramethylhexadecanoate) is a fatty acid with a hydroxyl group. It can be synthesized by the hydroxylation of phytanic acid in the peroxisome and is used as an intermediate in the synthesis of other types of fatty acids. Coenzyme A S-(3,7,11,15-tetramethylhexadecanoate) has been shown to have antihepatotoxic effects. In vitro method studies have shown that it prevents hepatic steatosis by decreasing lipid accumulation and increasing lipid oxidation. Coenzyme A S-(3,7,11,15-tetramethylhexadecanoate) also binds iron and may play a role in iron absorption or transport.
Propriétés chimiques
Question d’ordre technique sur : 3D-WFA62245 Coenzyme A S-(3,7,11,15-tetramethylhexadecanoate)
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages